date:Jun 28, 2013
roductivity segment.
Net sales edged up 0.7% to $4.25 billion, below the $4.41 billion expected by analysts surveyed by Thomson Reuters.
Gross margin narrowed to 53.2% from 56% as input costs rose 7%.
Monsanto's seeds and genomics business - the company's biggest top-line contributor - saw a 2.4% decrease in sales to $3.05 billion. Meanwhile, revenue from agricultural productivity jumped 9.4% to $1.19 billion.
Monsanto's revenue for the most part has improved over the past two years.
Shares